Published in Am J Respir Crit Care Med on October 14, 2004
Oxidants and the pathogenesis of lung diseases. J Allergy Clin Immunol (2008) 1.91
Ozone and pulmonary innate immunity. Proc Am Thorac Soc (2007) 1.61
Interactions between glutathione S-transferase P1, tumor necrosis factor, and traffic-related air pollution for development of childhood allergic disease. Environ Health Perspect (2008) 1.40
Signal transduction pathways of tumor necrosis factor--mediated lung injury induced by ozone in mice. Am J Respir Crit Care Med (2007) 1.37
Origin and health impacts of emissions of toxic by-products and fine particles from combustion and thermal treatment of hazardous wastes and materials. Environ Health Perspect (2006) 1.33
Gene-air pollution interactions in asthma. Proc Am Thorac Soc (2007) 1.27
Associations of tumor necrosis factor G-308A with childhood asthma and wheezing. Am J Respir Crit Care Med (2006) 1.21
Traffic-related air pollution, oxidative stress genes, and asthma (ECHRS). Environ Health Perspect (2009) 1.18
Parental smoking modifies the relation between genetic variation in tumor necrosis factor-alpha (TNF) and childhood asthma. Environ Health Perspect (2007) 1.10
Updates on the COPD gene list. Int J Chron Obstruct Pulmon Dis (2012) 1.08
Allergic diseases and air pollution. Asia Pac Allergy (2013) 1.03
Ambient ozone and pulmonary innate immunity. Immunol Res (2011) 0.93
Glutathione deficient C57BL/6J mice are not sensitized to ozone-induced lung injury. Biochem Biophys Res Commun (2010) 0.91
Ozone-induced lung injury and sterile inflammation. Role of toll-like receptor 4. Exp Mol Pathol (2012) 0.90
Identification of novel susceptibility genes in ozone-induced inflammation in mice. Eur Respir J (2009) 0.89
Impact of aging on pulmonary responses to acute ozone exposure in mice: role of TNFR1. Inhal Toxicol (2011) 0.87
Augmented pulmonary responses to acute ozone exposure in obese mice: roles of TNFR2 and IL-13. Environ Health Perspect (2013) 0.86
Identification of the Mhc region as an asthma susceptibility locus in recombinant congenic mice. Am J Respir Cell Mol Biol (2010) 0.80
Modification of the association between PM10 and lung function decline by cadherin 13 polymorphisms in the SAPALDIA cohort: a genome-wide interaction analysis. Environ Health Perspect (2014) 0.80
Association study of genes associated to asthma in a specific environment, in an asthma familial collection located in a rural area influenced by different industries. Int J Environ Res Public Health (2012) 0.79
Retracted The role of the extracellular matrix protein mindin in airway response to environmental airways injury. Environ Health Perspect (2011) 0.79
Gene-environment interaction from international cohorts: impact on development and evolution of occupational and environmental lung and airway disease. Semin Respir Crit Care Med (2015) 0.77
Children's Inter-Individual Variability and Asthma Development. Int J Health Sci (Qassim) (2015) 0.75
Air pollution and health. Lancet (2002) 9.57
Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature (2002) 8.28
Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med (2002) 6.52
Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med (2005) 6.05
Role of deficient type III interferon-lambda production in asthma exacerbations. Nat Med (2006) 5.90
Genome-wide association scan meta-analysis identifies three Loci influencing adiposity and fat distribution. PLoS Genet (2009) 5.81
Genome-wide association study identifies five loci associated with lung function. Nat Genet (2009) 4.10
Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma. J Allergy Clin Immunol (2010) 3.12
Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet (2002) 3.11
Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function. Nat Genet (2011) 3.03
Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study. Am J Respir Crit Care Med (2007) 2.93
Pathogenesis of asthma. Clin Exp Allergy (2008) 2.93
Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma. Am J Respir Crit Care Med (2004) 2.81
Efficacy of a new once-daily long-acting inhaled beta2-agonist indacaterol versus twice-daily formoterol in COPD. Thorax (2010) 2.79
The airway epithelium: structural and functional properties in health and disease. Respirology (2003) 2.73
Defective epithelial barrier function in asthma. J Allergy Clin Immunol (2011) 2.73
The mouse trap: It still yields few answers in asthma. Am J Respir Crit Care Med (2006) 2.68
A randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthma. Am J Respir Crit Care Med (2009) 2.56
Indoor air contamination during a waterpipe (narghile) smoking session. Food Chem Toxicol (2009) 2.48
Expression of genes involved in oxidative stress responses in airway epithelial cells of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2006) 2.44
Predictors of survival in COPD patients with chronic hypercapnic respiratory failure receiving noninvasive home ventilation. Chest (2007) 2.36
The role of the mast cell in the pathophysiology of asthma. J Allergy Clin Immunol (2006) 2.35
Whole-Body Plethysmography in Suspected Asthma: A Prospective Study of Its Added Diagnostic Value in 302 Patients. Dtsch Arztebl Int (2015) 2.34
Airway remodeling in asthma: new insights. J Allergy Clin Immunol (2003) 2.32
PI3Kgamma inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus. Nat Med (2005) 2.28
The metabolic syndrome in patients with chronic bronchitis and COPD: frequency and associated consequences for systemic inflammation and physical inactivity. Chest (2009) 2.21
Cubic exact solutions for the estimation of pairwise haplotype frequencies: implications for linkage disequilibrium analyses and a web tool 'CubeX'. BMC Bioinformatics (2007) 2.15
Effect of five genetic variants associated with lung function on the risk of chronic obstructive lung disease, and their joint effects on lung function. Am J Respir Crit Care Med (2011) 2.07
Decreasing cardiac chamber sizes and associated heart dysfunction in COPD: role of hyperinflation. Chest (2010) 2.02
The European Respiratory Society plans its future: the 2013-2018 strategic plan. Eur Respir J (2014) 2.02
Personal exposure to nitrogen dioxide (NO2) and the severity of virus-induced asthma in children. Lancet (2003) 1.96
Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial. Am J Respir Crit Care Med (2002) 1.90
New loci associated with birth weight identify genetic links between intrauterine growth and adult height and metabolism. Nat Genet (2012) 1.90
Increased interleukin-4, interleukin-5, and interferon-gamma in airway CD4+ and CD8+ T cells in atopic asthma. Am J Respir Crit Care Med (2004) 1.88
Severe asthma in adults: what are the important questions? J Allergy Clin Immunol (2007) 1.85
Airway epithelial transcription factor NK2 homeobox 1 inhibits mucous cell metaplasia and Th2 inflammation. Am J Respir Crit Care Med (2011) 1.84
Use of self-expanding metal stents to treat malignant colorectal obstruction in general endoscopic practice (with videos). Gastrointest Endosc (2006) 1.78
Asthmatic bronchial epithelium is more susceptible to oxidant-induced apoptosis. Am J Respir Cell Mol Biol (2002) 1.73
Factors associated with mortality after an asthma admission: a national United Kingdom database analysis. Respir Med (2007) 1.71
CXCR2 Antagonist MK-7123. A Phase 2 Proof-of-Concept Trial for Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med (2015) 1.70
Assessment of lymph node tuberculosis in northern Germany: a clinical review. Chest (2002) 1.66
Detection of obstructive sleep apnoea by an electronic nose. Eur Respir J (2012) 1.66
Responses to bronchial challenge submitted for approval to use inhaled beta2-agonists before an event at the 2002 Winter Olympics. J Allergy Clin Immunol (2003) 1.65
Pulmonary biomarkers in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2006) 1.63
The role of histamine degradation gene polymorphisms in moderating the effects of food additives on children's ADHD symptoms. Am J Psychiatry (2010) 1.60
Gene expression subtypes in patients with chronic fatigue syndrome/myalgic encephalomyelitis. J Infect Dis (2008) 1.59
Rhinovirus infection increases 5-lipoxygenase and cyclooxygenase-2 in bronchial biopsy specimens from nonatopic subjects. J Infect Dis (2002) 1.59
Cooperative effects of Th2 cytokines and allergen on normal and asthmatic bronchial epithelial cells. J Immunol (2002) 1.51
Lung fibroblast repair functions in patients with chronic obstructive pulmonary disease are altered by multiple mechanisms. Am J Respir Crit Care Med (2008) 1.50
Comparison of two devices and two breathing patterns for exhaled breath condensate sampling. PLoS One (2011) 1.45
Onset and duration of action of formoterol and tiotropium in patients with moderate to severe COPD. Respiration (2006) 1.45
Tumor necrosis factor alpha (TNF-α) autoregulates its expression and induces adhesion molecule expression in asthma. Clin Immunol (2011) 1.45
E-cigarettes--prevention, pulmonary health, and addiction. Dtsch Arztebl Int (2014) 1.43
The splicing and fate of ADAM33 transcripts in primary human airways fibroblasts. Am J Respir Cell Mol Biol (2004) 1.42
Efficacy of aclidinium bromide 400 μg twice daily compared with placebo and tiotropium in patients with moderate to severe COPD. Chest (2011) 1.40
Polymorphisms in a disintegrin and metalloprotease 33 (ADAM33) predict impaired early-life lung function. Am J Respir Crit Care Med (2005) 1.40
Next generation exome sequencing of paediatric inflammatory bowel disease patients identifies rare and novel variants in candidate genes. Gut (2012) 1.39
Autocrine ligands for the epidermal growth factor receptor mediate interleukin-8 release from bronchial epithelial cells in response to cigarette smoke. Am J Respir Cell Mol Biol (2002) 1.36
Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone. Respir Med (2007) 1.35
Identification of PCDH1 as a novel susceptibility gene for bronchial hyperresponsiveness. Am J Respir Crit Care Med (2009) 1.35
Expert elicitation on ultrafine particles: likelihood of health effects and causal pathways. Part Fibre Toxicol (2009) 1.35
Increased expression of p21(waf) cyclin-dependent kinase inhibitor in asthmatic bronchial epithelium. Am J Respir Cell Mol Biol (2003) 1.35
IFN-gamma-induced protein 10 is a novel biomarker of rhinovirus-induced asthma exacerbations. J Allergy Clin Immunol (2007) 1.34
Passive smoking exposure: a risk factor for chronic bronchitis and asthma in adults? Chest (2002) 1.34
A birth cohort study of subjects at risk of atopy: twenty-two-year follow-up of wheeze and atopic status. Am J Respir Crit Care Med (2002) 1.33
Reduced miR-146a increases prostaglandin E₂in chronic obstructive pulmonary disease fibroblasts. Am J Respir Crit Care Med (2010) 1.33
Animal models of asthma: value, limitations and opportunities for alternative approaches. Drug Discov Today (2011) 1.32
Genetics of allergic disease. J Allergy Clin Immunol (2010) 1.31
Integrating indacaterol dose selection in a clinical study in COPD using an adaptive seamless design. Pulm Pharmacol Ther (2010) 1.30
Enzyme potentiated desensitisation in treatment of seasonal allergic rhinitis: double blind randomised controlled study. BMJ (2003) 1.29
Allergic diseases and asthma: a major global health concern. Curr Opin Allergy Clin Immunol (2012) 1.26
Physical activity monitoring in COPD: compliance and associations with clinical characteristics in a multicenter study. Respir Med (2011) 1.23
The interaction of genetic variants and DNA methylation of the interleukin-4 receptor gene increase the risk of asthma at age 18 years. Clin Epigenetics (2013) 1.22
Analysis of novel disease-related genes in bronchial asthma. Cytokine (2002) 1.22
The soluble form of a disintegrin and metalloprotease 33 promotes angiogenesis: implications for airway remodeling in asthma. J Allergy Clin Immunol (2008) 1.21
Comprehensive characterisation of pulmonary and serum surfactant protein D in COPD. Respir Res (2011) 1.20
Double-stranded RNA induces disproportionate expression of thymic stromal lymphopoietin versus interferon-beta in bronchial epithelial cells from donors with asthma. Thorax (2010) 1.20
Prenatal and infant acetaminophen exposure, antioxidant gene polymorphisms, and childhood asthma. J Allergy Clin Immunol (2010) 1.18
Glutathione-S-transferase genes and asthma phenotypes: a Human Genome Epidemiology (HuGE) systematic review and meta-analysis including unpublished data. Int J Epidemiol (2009) 1.17
Spatial interactions between dendritic cells and sensory nerves in allergic airway inflammation. Am J Respir Cell Mol Biol (2007) 1.17
Relationship of vitamin D status to adult lung function and COPD. Thorax (2011) 1.16
IL-4 receptor alpha is an important modulator of IL-4 and IL-13 receptor binding: implications for the development of therapeutic targets. J Immunol (2006) 1.15
Aging and induced senescence as factors in the pathogenesis of lung emphysema. Respir Med (2008) 1.14
Expression of c-erbB receptors and ligands in the bronchial epithelium of asthmatic subjects. J Allergy Clin Immunol (2002) 1.13
Association of depression and anxiety with health care use and quality of life in asthma patients. Respir Med (2006) 1.13